Efficacy and safety of S-1 following gemcitabine with cisplatin for advanced biliary tract cancer

Background Combination therapy of gemcitabine with cisplatin (GC) is a standard first-line therapy for unresectable or recurrent biliary tract cancer (BTC). S-1 is often used as a second-line therapy in clinical practice, based on the results of some clinical studies investigating its efficacy and s...

Descripción completa

Detalles Bibliográficos
Autores principales: Inoue, Hiroto, Todaka, Akiko, Yamazaki, Kentaro, Fushiki, Kunihiro, Shirasu, Hiromichi, Kawakami, Takeshi, Tsushima, Takahiro, Hamauchi, Satoshi, Yokota, Tomoya, Machida, Nozomu, Fukutomi, Akira, Onozawa, Yusuke, Andoh, Akira, Yasui, Hirofumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426227/
https://www.ncbi.nlm.nih.gov/pubmed/33835357
http://dx.doi.org/10.1007/s10637-021-01098-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426227/
https://www.ncbi.nlm.nih.gov/pubmed/33835357
http://dx.doi.org/10.1007/s10637-021-01098-2

Ejemplares similares